KR20140019346A - 생체 활성 식물성 화장품 조성물 및 이의 제조 방법 - Google Patents
생체 활성 식물성 화장품 조성물 및 이의 제조 방법 Download PDFInfo
- Publication number
- KR20140019346A KR20140019346A KR1020137024041A KR20137024041A KR20140019346A KR 20140019346 A KR20140019346 A KR 20140019346A KR 1020137024041 A KR1020137024041 A KR 1020137024041A KR 20137024041 A KR20137024041 A KR 20137024041A KR 20140019346 A KR20140019346 A KR 20140019346A
- Authority
- KR
- South Korea
- Prior art keywords
- cell
- plant
- fraction
- cosmetic
- bioactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 218
- 239000000203 mixture Substances 0.000 title claims abstract description 162
- 238000000034 method Methods 0.000 title claims abstract description 155
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 103
- 238000004519 manufacturing process Methods 0.000 title description 23
- 230000008569 process Effects 0.000 title description 18
- 210000002966 serum Anatomy 0.000 claims abstract description 185
- 235000013311 vegetables Nutrition 0.000 claims abstract description 180
- 239000012528 membrane Substances 0.000 claims abstract description 137
- 239000012530 fluid Substances 0.000 claims abstract description 88
- 230000000699 topical effect Effects 0.000 claims abstract description 13
- 238000009472 formulation Methods 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims description 299
- 210000004027 cell Anatomy 0.000 claims description 271
- 239000002028 Biomass Substances 0.000 claims description 83
- 230000003078 antioxidant effect Effects 0.000 claims description 61
- 230000005764 inhibitory process Effects 0.000 claims description 57
- 239000000126 substance Substances 0.000 claims description 50
- 230000000694 effects Effects 0.000 claims description 46
- 239000003963 antioxidant agent Substances 0.000 claims description 43
- 230000010261 cell growth Effects 0.000 claims description 41
- 238000002360 preparation method Methods 0.000 claims description 39
- 239000006228 supernatant Substances 0.000 claims description 38
- 150000002978 peroxides Chemical class 0.000 claims description 37
- 230000002000 scavenging effect Effects 0.000 claims description 36
- 239000000706 filtrate Substances 0.000 claims description 33
- 230000001086 cytosolic effect Effects 0.000 claims description 30
- 238000011282 treatment Methods 0.000 claims description 30
- 230000004936 stimulating effect Effects 0.000 claims description 28
- 210000000440 neutrophil Anatomy 0.000 claims description 26
- 240000002853 Nelumbo nucifera Species 0.000 claims description 24
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 23
- 238000004880 explosion Methods 0.000 claims description 22
- 239000003755 preservative agent Substances 0.000 claims description 22
- 230000000241 respiratory effect Effects 0.000 claims description 22
- 238000000926 separation method Methods 0.000 claims description 21
- 238000012545 processing Methods 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 241000124008 Mammalia Species 0.000 claims description 16
- 102100030497 Cytochrome c Human genes 0.000 claims description 15
- 108010075031 Cytochromes c Proteins 0.000 claims description 15
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 15
- 230000009467 reduction Effects 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- 235000015724 Trifolium pratense Nutrition 0.000 claims description 13
- 230000035755 proliferation Effects 0.000 claims description 13
- 235000013526 red clover Nutrition 0.000 claims description 13
- 238000005345 coagulation Methods 0.000 claims description 12
- 230000015271 coagulation Effects 0.000 claims description 12
- 230000002335 preservative effect Effects 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 11
- 238000001556 precipitation Methods 0.000 claims description 10
- 230000000638 stimulation Effects 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 9
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 238000004448 titration Methods 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 8
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 7
- 230000001747 exhibiting effect Effects 0.000 claims description 7
- 235000010241 potassium sorbate Nutrition 0.000 claims description 7
- 239000004302 potassium sorbate Substances 0.000 claims description 7
- 229940069338 potassium sorbate Drugs 0.000 claims description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 7
- 235000010234 sodium benzoate Nutrition 0.000 claims description 7
- 239000004299 sodium benzoate Substances 0.000 claims description 7
- 235000010268 sodium methyl p-hydroxybenzoate Nutrition 0.000 claims description 7
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 claims description 7
- 240000002913 Trifolium pratense Species 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 6
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 6
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 238000003828 vacuum filtration Methods 0.000 claims description 5
- 235000015165 citric acid Nutrition 0.000 claims description 4
- 230000001687 destabilization Effects 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 4
- 230000003833 cell viability Effects 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000008309 hydrophilic cream Substances 0.000 claims description 3
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 claims description 3
- 230000000368 destabilizing effect Effects 0.000 claims description 2
- 238000000909 electrodialysis Methods 0.000 claims description 2
- 230000001629 suppression Effects 0.000 claims description 2
- 241000219793 Trifolium Species 0.000 claims 2
- 235000005807 Nelumbo Nutrition 0.000 claims 1
- CESGKXMBHGUQTB-VONOSFMSSA-N [(1S,2S,6R,10S,11R,13S,14R,15R)-1,6,14-trihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(OC(=O)CCCCCCCCCCCCC)C(C)(C)[C@H]3[C@@H]21 CESGKXMBHGUQTB-VONOSFMSSA-N 0.000 claims 1
- 230000001112 coagulating effect Effects 0.000 claims 1
- 239000008406 cosmetic ingredient Substances 0.000 description 210
- 230000002401 inhibitory effect Effects 0.000 description 66
- 210000001519 tissue Anatomy 0.000 description 60
- 210000003491 skin Anatomy 0.000 description 54
- 239000000243 solution Substances 0.000 description 40
- 240000001432 Calendula officinalis Species 0.000 description 39
- 239000000047 product Substances 0.000 description 38
- 235000006708 antioxidants Nutrition 0.000 description 37
- 235000005881 Calendula officinalis Nutrition 0.000 description 34
- 235000002020 sage Nutrition 0.000 description 31
- 238000012360 testing method Methods 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 230000000813 microbial effect Effects 0.000 description 26
- 238000004458 analytical method Methods 0.000 description 25
- 238000003556 assay Methods 0.000 description 23
- 230000002797 proteolythic effect Effects 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 22
- 108090000790 Enzymes Proteins 0.000 description 22
- 229940088598 enzyme Drugs 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 239000013641 positive control Substances 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- 244000178870 Lavandula angustifolia Species 0.000 description 20
- 238000011156 evaluation Methods 0.000 description 20
- -1 peroxide anions Chemical class 0.000 description 20
- 240000005979 Hordeum vulgare Species 0.000 description 19
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 19
- 102000035195 Peptidases Human genes 0.000 description 19
- 108091005804 Peptidases Proteins 0.000 description 19
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 18
- 235000007340 Hordeum vulgare Nutrition 0.000 description 17
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 230000002849 elastaseinhibitory effect Effects 0.000 description 16
- 239000000284 extract Substances 0.000 description 15
- 238000003306 harvesting Methods 0.000 description 15
- 239000011159 matrix material Substances 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 14
- 238000000605 extraction Methods 0.000 description 14
- 240000007164 Salvia officinalis Species 0.000 description 13
- 238000005520 cutting process Methods 0.000 description 13
- 238000009826 distribution Methods 0.000 description 13
- 210000002950 fibroblast Anatomy 0.000 description 13
- 239000001102 lavandula vera Substances 0.000 description 13
- 235000018219 lavender Nutrition 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 238000003860 storage Methods 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 240000004658 Medicago sativa Species 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000003110 anti-inflammatory effect Effects 0.000 description 12
- 230000004663 cell proliferation Effects 0.000 description 12
- 231100000433 cytotoxic Toxicity 0.000 description 12
- 230000001472 cytotoxic effect Effects 0.000 description 12
- 230000006378 damage Effects 0.000 description 12
- 239000003642 reactive oxygen metabolite Substances 0.000 description 12
- 230000006641 stabilisation Effects 0.000 description 12
- 238000011105 stabilization Methods 0.000 description 12
- 241000219823 Medicago Species 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 244000052769 pathogen Species 0.000 description 11
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 11
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 10
- 108010028275 Leukocyte Elastase Proteins 0.000 description 10
- 102000016799 Leukocyte elastase Human genes 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 102000003425 Tyrosinase Human genes 0.000 description 10
- 108060008724 Tyrosinase Proteins 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 102000004142 Trypsin Human genes 0.000 description 9
- 108090000631 Trypsin Proteins 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000012588 trypsin Substances 0.000 description 9
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 8
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 8
- 210000004969 inflammatory cell Anatomy 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 8
- 229920000053 polysorbate 80 Polymers 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 7
- 206010067482 No adverse event Diseases 0.000 description 7
- 102000016387 Pancreatic elastase Human genes 0.000 description 7
- 108010067372 Pancreatic elastase Proteins 0.000 description 7
- 235000002912 Salvia officinalis Nutrition 0.000 description 7
- 230000003013 cytotoxicity Effects 0.000 description 7
- 231100000135 cytotoxicity Toxicity 0.000 description 7
- 230000008472 epithelial growth Effects 0.000 description 7
- 239000003102 growth factor Substances 0.000 description 7
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 235000010624 Medicago sativa Nutrition 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000017276 Salvia Nutrition 0.000 description 6
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 210000002808 connective tissue Anatomy 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 210000004927 skin cell Anatomy 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 238000007696 Kjeldahl method Methods 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 238000005273 aeration Methods 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 230000007123 defense Effects 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 230000002427 irreversible effect Effects 0.000 description 5
- 238000002386 leaching Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229960004441 tyrosine Drugs 0.000 description 5
- 238000002211 ultraviolet spectrum Methods 0.000 description 5
- CCTFAOUOYLVUFG-UHFFFAOYSA-N 2-(1-amino-1-imino-2-methylpropan-2-yl)azo-2-methylpropanimidamide Chemical compound NC(=N)C(C)(C)N=NC(C)(C)C(N)=N CCTFAOUOYLVUFG-UHFFFAOYSA-N 0.000 description 4
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000208838 Asteraceae Species 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- 235000003880 Calendula Nutrition 0.000 description 4
- 206010012442 Dermatitis contact Diseases 0.000 description 4
- 241000220485 Fabaceae Species 0.000 description 4
- 102000013382 Gelatinases Human genes 0.000 description 4
- 108010026132 Gelatinases Proteins 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 241000207923 Lamiaceae Species 0.000 description 4
- 241000209504 Poaceae Species 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 208000010247 contact dermatitis Diseases 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 235000021374 legumes Nutrition 0.000 description 4
- 229960005375 lutein Drugs 0.000 description 4
- 235000012680 lutein Nutrition 0.000 description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 4
- 239000001656 lutein Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 229940075420 xanthine Drugs 0.000 description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 102100033220 Xanthine oxidase Human genes 0.000 description 3
- 108010093894 Xanthine oxidase Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- NNKKTZOEKDFTBU-YBEGLDIGSA-N cinidon ethyl Chemical compound C1=C(Cl)C(/C=C(\Cl)C(=O)OCC)=CC(N2C(C3=C(CCCC3)C2=O)=O)=C1 NNKKTZOEKDFTBU-YBEGLDIGSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012543 microbiological analysis Methods 0.000 description 3
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012875 nonionic emulsifier Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000000451 tissue damage Effects 0.000 description 3
- 231100000827 tissue damage Toxicity 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 2
- 102000056189 Neutrophil collagenases Human genes 0.000 description 2
- 108030001564 Neutrophil collagenases Proteins 0.000 description 2
- 208000012868 Overgrowth Diseases 0.000 description 2
- 241000589774 Pseudomonas sp. Species 0.000 description 2
- 206010037898 Rash vesicular Diseases 0.000 description 2
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 238000013103 analytical ultracentrifugation Methods 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003602 elastase inhibitor Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000013020 final formulation Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001056 green pigment Substances 0.000 description 2
- 230000003463 hyperproliferative effect Effects 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000006749 inflammatory damage Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000464 low-speed centrifugation Methods 0.000 description 2
- 230000036564 melanin content Effects 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- GUAQVFRUPZBRJQ-UHFFFAOYSA-N n-(3-aminopropyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCCCN GUAQVFRUPZBRJQ-UHFFFAOYSA-N 0.000 description 2
- DEOKFPFLXFNAON-NTISSMGPSA-N n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]benzamide;hydrochloride Chemical compound Cl.N([C@@H](CCCN=C(N)N)C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)C(=O)C1=CC=CC=C1 DEOKFPFLXFNAON-NTISSMGPSA-N 0.000 description 2
- 230000017095 negative regulation of cell growth Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 238000012599 radical scavenging assay Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000012049 topical pharmaceutical composition Substances 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- VIYKYVYAKVNDPS-HKGPVOKGSA-N (2s)-2-azanyl-3-[3,4-bis(oxidanyl)phenyl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 VIYKYVYAKVNDPS-HKGPVOKGSA-N 0.000 description 1
- WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
- AIBRSVLEQRWAEG-UHFFFAOYSA-N 3,9-bis(2,4-ditert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP1OCC2(COP(OC=3C(=CC(=CC=3)C(C)(C)C)C(C)(C)C)OC2)CO1 AIBRSVLEQRWAEG-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 229940122858 Elastase inhibitor Drugs 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical group [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000209219 Hordeum Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- DEOKFPFLXFNAON-UHFFFAOYSA-N N-α-Benzoyl-DL-arginine 4-nitroanilide hydrochloride Chemical compound Cl.C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(CCCN=C(N)N)NC(=O)C1=CC=CC=C1 DEOKFPFLXFNAON-UHFFFAOYSA-N 0.000 description 1
- 102100030411 Neutrophil collagenase Human genes 0.000 description 1
- 101710118230 Neutrophil collagenase Proteins 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607149 Salmonella sp. Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 241001645022 Tripolium Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- NFXWJYUDIOHFAW-UHFFFAOYSA-N acetic acid;tetradecanoic acid Chemical compound CC(O)=O.CCCCCCCCCCCCCC(O)=O NFXWJYUDIOHFAW-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 108040001319 catechol oxidase activity proteins Proteins 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000005414 inactive ingredient Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000013038 irreversible inhibitor Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003591 leukocyte elastase inhibitor Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 108010058393 monophenolase Proteins 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008654 plant damage Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 230000006965 reversible inhibition Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/032,187 | 2011-02-22 | ||
| US13/032,187 US8277852B2 (en) | 2002-01-25 | 2011-02-22 | Bioactive botanical cosmetic compositions and processes for their production |
| PCT/US2012/025899 WO2012148527A2 (en) | 2011-02-22 | 2012-02-21 | Bioactive botanical cosmetic compositions and processes for their production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140019346A true KR20140019346A (ko) | 2014-02-14 |
Family
ID=46025863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020137024041A Abandoned KR20140019346A (ko) | 2011-02-22 | 2012-02-21 | 생체 활성 식물성 화장품 조성물 및 이의 제조 방법 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8277852B2 (enExample) |
| EP (1) | EP2677999B1 (enExample) |
| JP (2) | JP6246593B2 (enExample) |
| KR (1) | KR20140019346A (enExample) |
| CN (2) | CN103547253A (enExample) |
| AU (2) | AU2012249188A1 (enExample) |
| BR (1) | BR112013021274A2 (enExample) |
| CA (1) | CA2827773A1 (enExample) |
| MY (1) | MY172073A (enExample) |
| WO (1) | WO2012148527A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7442391B2 (en) * | 2002-01-25 | 2008-10-28 | Integrated Botanical Technologies, Llc | Bioactive botanical cosmetic compositions and processes for their production |
| US8277852B2 (en) * | 2002-01-25 | 2012-10-02 | Akzo Nobel Surface Chemistry Llc | Bioactive botanical cosmetic compositions and processes for their production |
| CN103402494B (zh) * | 2011-02-22 | 2017-01-18 | 宝洁公司 | 使用包含榕树、莲花和三叶草浆液组分的组合物改善老化皮肤外观的方法 |
| CN102949299B (zh) * | 2011-12-20 | 2014-08-06 | 上海莱博生物科技有限公司 | 荷叶碱或含其的植物提取物的应用 |
| KR20150083996A (ko) * | 2012-11-14 | 2015-07-21 | 아크조 노벨 케미칼즈 인터내셔널 비.브이. | 생활성 식물 조성물의 제조 방법, 및 상기 방법으로 제조되는 조성물 |
| KR101394430B1 (ko) | 2012-12-26 | 2014-05-14 | 시흥시 | 연근 추출물이 함유된 화장품 제조방법 |
| SG11201506444RA (en) * | 2013-03-13 | 2015-09-29 | Akzo Nobel Chemicals Int Bv | Bioactive botanical compositions and uses thereof |
| AU2014230873B2 (en) * | 2013-03-15 | 2016-10-06 | Isp Investments Inc. | Bioactive compositions from fruit and methods for their production |
| CN104473832A (zh) * | 2014-11-17 | 2015-04-01 | 青岛厚科信息工程有限公司 | 一种抗菌洁面乳及其制备方法 |
| US11154492B2 (en) * | 2016-01-15 | 2021-10-26 | Isp Investments Llc | Bioactive compositions from ginseng plant (Panax spp.) and methods for their production and use |
| KR20180115751A (ko) | 2016-02-25 | 2018-10-23 | 아이에스피 인베스트먼츠 엘엘씨 | 살아있는 식물로부터 수득한 성분에 의한 태양광의 유해 효과의 완화 |
| ITUA20162223A1 (it) * | 2016-04-01 | 2017-10-01 | Linnea Sa | Composizione topica comprendente estratti vegetali |
| EP3509706B1 (en) * | 2016-09-07 | 2021-11-03 | ISP Investments LLC | Method for increasing lipolysis using a composition comprising bioactive nelumbo nucifera (lotus) extract |
| CN114788791A (zh) | 2017-06-23 | 2022-07-26 | 宝洁公司 | 用于改善皮肤外观的组合物和方法 |
| HU231226B1 (hu) * | 2018-01-31 | 2022-03-28 | Debreceni Egyetem | Növényifehérje-koagulum előállítására szolgáló eljárás |
| US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
| CN110876702A (zh) * | 2019-12-09 | 2020-03-13 | 健民药业集团股份有限公司 | 红车轴草提取物用作酪氨酸酶抑制剂的用途 |
| US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2559459A (en) * | 1949-02-01 | 1951-07-03 | Western Condensing Co | Vegetable treatment process |
| US3849391A (en) * | 1969-02-17 | 1974-11-19 | Grain Processing Corp | Recovery of protein |
| US3684520A (en) * | 1969-12-09 | 1972-08-15 | Us Agriculture | Fractionation of leafy green crops |
| US3775133A (en) * | 1971-08-02 | 1973-11-27 | W Batley | Fractionation of alfalfa wetted with molasses serum |
| US3821346A (en) * | 1971-08-02 | 1974-06-28 | W Batley | Pet litter produced by recycled molasses serum |
| US3957774A (en) * | 1972-04-17 | 1976-05-18 | L'oreal | N-morpholinomethyl-n-'-substituted ethyl and propylureas |
| US3799806A (en) * | 1972-04-20 | 1974-03-26 | Danske Sukkerfab | Process for the purification and clarification of sugar juices,involving ultrafiltration |
| US3823128A (en) * | 1972-05-16 | 1974-07-09 | Us Agriculture | Preparation of edible protein from leafy green crops such as alfalfa |
| US4006078A (en) * | 1974-07-08 | 1977-02-01 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of soluble edible protein from leafy green crops |
| US3959246A (en) * | 1974-07-08 | 1976-05-25 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of soluble edible protein from leafy green crops |
| FR2294647A1 (fr) * | 1974-11-04 | 1976-07-16 | France Luzerne | Procede de traitement de vegetaux verts feuillus en vue d'une extraction de proteines dans les jus de pressage et d'une deshydratation economique du tourteau |
| GB1430566A (en) * | 1974-11-15 | 1976-03-31 | Nestel Sa | Isolation of proteins |
| US3993794A (en) * | 1976-01-15 | 1976-11-23 | The United States Of America As Represented By The Secretary Of Agriculture | Method for texturizing proteins |
| HU174943B (hu) | 1976-06-30 | 1980-04-28 | Vepex Foevallalkozasi Iroda Rt | Sposob poluchenija koncentratov rastitel'nogo belka i pigmenta |
| US4077950A (en) * | 1976-07-12 | 1978-03-07 | Source Proteins, Inc. | Process for the recovery of substantially water-soluble non-toxic protein compounds from fresh non-woody vegetation |
| US4250197A (en) * | 1976-10-25 | 1981-02-10 | Vepex Fovallalkopasi Iroda Rt. | Method for processing plant protein |
| US4130553A (en) * | 1977-01-05 | 1978-12-19 | Batley Jr William R | Process for improving the nutritional value of green plant protein |
| US4178372A (en) * | 1978-03-06 | 1979-12-11 | Coats Billy C | Hypoallergenic stabilized aloe vera gel |
| CA1099576A (en) * | 1978-03-23 | 1981-04-21 | Chester D. Myers | Improved process for isolation of proteins |
| US4234620A (en) * | 1978-12-26 | 1980-11-18 | A. E. Staley Manufacturing Company | Water-soluble vegetable protein aggregates |
| GB2054343B (en) | 1979-07-20 | 1983-08-24 | Energiagazdalkodasi Intezet | Preserving green vegetable matter |
| US4347324A (en) * | 1979-09-24 | 1982-08-31 | Leaf Proteins, Inc. | Process for isolation of proteins from plant leaves |
| EP0063124B1 (fr) * | 1980-08-13 | 1985-02-06 | Verniers S.A. | Procede d'obtention de jus clairs de vegetaux et de recuperation de constituants valorisables |
| US4359530A (en) * | 1980-09-08 | 1982-11-16 | Aluminum Company Of America | Protein extraction from green crops |
| US4334024A (en) * | 1980-11-03 | 1982-06-08 | Sarjit Johal | Preparation and crystallization of fraction I protein from plant sources |
| JPS5914451B2 (ja) | 1981-03-09 | 1984-04-04 | 日本薬品開発株式会社 | 植物緑葉源抗炎症剤 |
| US4333871A (en) * | 1981-03-18 | 1982-06-08 | International Harvester Company | Coagulation method for preparing leaf protein concentrates (LPC) from plant foliage |
| US4421682A (en) * | 1981-04-06 | 1983-12-20 | The United States Of America As Represented By The Secretary Of Agriculture | Heating of proteinaceous liquids |
| FR2523976B1 (fr) * | 1982-03-26 | 1985-08-30 | Pasteur Institut | Nouveau produit proteique, obtention et application comme medicament, en particulier immunoregulateur et antiallergique |
| US4588691A (en) * | 1984-02-29 | 1986-05-13 | Johal Sarjit S | Method for preparation of Fraction I protein and by-products thereof |
| CH671322A5 (enExample) * | 1986-09-29 | 1989-08-31 | Bucher Guyer Ag Masch | |
| FR2632308B1 (fr) * | 1988-06-07 | 1991-08-16 | Fondation Nale Transfusion San | Procede et installation de fractionnement en continu de proteines vegetales animales ou humaines |
| JPH111686A (ja) | 1990-05-14 | 1999-01-06 | Yoshihide Hagiwara | 抗酸化剤 |
| US5723149A (en) * | 1990-11-21 | 1998-03-03 | Lvmh Recherche | Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss |
| JP2986565B2 (ja) * | 1991-02-04 | 1999-12-06 | 御木本製薬株式会社 | 化粧料 |
| US6221363B1 (en) * | 1991-07-11 | 2001-04-24 | Baxter Aktiengesellschaft | Vaccine for the prevention of lyme disease |
| US5798446A (en) * | 1991-10-10 | 1998-08-25 | Nupron Gmbh Proteinwerk | Method of extracting proteins utilizable in foodstuff from a protein-containing substance |
| JPH05229921A (ja) | 1992-02-21 | 1993-09-07 | Nakano Vinegar Co Ltd | 発毛促進用組成物 |
| CH684924A5 (de) * | 1993-04-02 | 1995-02-15 | Bucher Guyer Ag Masch | Verfahren zum Trennen fester und flüssiger Anteile, sowie Vorrichtung zu dessen Durchführung. |
| US5433968A (en) * | 1993-04-23 | 1995-07-18 | Nestec S.A. | Process for producing a simulated meat product |
| US6123973A (en) * | 1993-07-30 | 2000-09-26 | Tillin, Inc. | Methods of preparation and using antimicrobial products |
| ATE163838T1 (de) * | 1993-08-17 | 1998-03-15 | Nestle Sa | Verfahren zum extrahieren von pflanzlicher antioxidanten in flüssiger form |
| US5777080A (en) * | 1994-05-09 | 1998-07-07 | The Board Of Trustees Of The University Of Arkansas | Highly soluble protein, method for making, and food products made thereof |
| AR002779A1 (es) * | 1995-07-10 | 1998-04-29 | Nestle Sa | Procedimiento para fabricar una leche de almendras de frutas. |
| US5925348A (en) * | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
| US6468564B1 (en) * | 1997-02-21 | 2002-10-22 | Clientele Beauty, Inc. | Topical compositions containing lotus for skin treatment |
| FR2751878B1 (fr) * | 1996-07-30 | 1998-09-04 | Oreal | Utilisation dans une composition d'un extrait d'au moins une labiee |
| EP0821967A1 (en) * | 1996-08-02 | 1998-02-04 | Institute For Advanced Skin Research Inc. | Composition for enhancing hyaluronic acid productivity and method for preparing same |
| JP3457813B2 (ja) * | 1996-11-07 | 2003-10-20 | 花王株式会社 | 化粧料 |
| IT1288257B1 (it) * | 1996-11-29 | 1998-09-11 | Paoli Ambrosi Gianfranco De | Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico |
| FR2769502B1 (fr) * | 1997-10-14 | 2000-04-14 | Sederma Sa | Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir du trefle (trifolium sp.) |
| US6037456A (en) * | 1998-03-10 | 2000-03-14 | Biosource Technologies, Inc. | Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| JPH11279069A (ja) * | 1998-03-27 | 1999-10-12 | Ichimaru Pharcos Co Ltd | 活性酸素消去剤 |
| US5994508A (en) * | 1998-04-13 | 1999-11-30 | Protein Technologies International, Inc. | Isoflavone rich protein isolate and process for producing |
| US6013771A (en) * | 1998-06-09 | 2000-01-11 | Protein Technologies International, Inc. | Isoflavone rich protein isolate and process for producing |
| DK1002521T3 (da) * | 1998-11-19 | 2002-11-11 | Isernhagen Heilmittelbetr Gmbh | Anvendelse af udtræk opnået ved ekstraktion med kuldioxid som deodoranter |
| JP2001122757A (ja) * | 1999-10-22 | 2001-05-08 | Naris Cosmetics Co Ltd | 活性酸素消去剤、抗酸化剤および化粧料 |
| US6436417B1 (en) * | 2001-06-25 | 2002-08-20 | Blistex Inc. | Acne treatment compositions |
| JP2003048846A (ja) * | 2001-07-31 | 2003-02-21 | Koei Kogyo Kk | コラゲナーゼ阻害剤及び抗老化用化粧料 |
| US7442391B2 (en) * | 2002-01-25 | 2008-10-28 | Integrated Botanical Technologies, Llc | Bioactive botanical cosmetic compositions and processes for their production |
| US8277852B2 (en) * | 2002-01-25 | 2012-10-02 | Akzo Nobel Surface Chemistry Llc | Bioactive botanical cosmetic compositions and processes for their production |
| EP1344516A1 (de) * | 2002-03-12 | 2003-09-17 | Cognis Iberia, S.L. | Antioxidative Zubereitungen |
| WO2004017934A1 (de) * | 2002-08-16 | 2004-03-04 | Coty B.V. | Hautglättendes kosmetikum auf basis von pflanzenextrakten |
| JP2004231558A (ja) * | 2003-01-30 | 2004-08-19 | Nonogawa Shoji Kk | 美白用皮膚外用剤 |
| DE10329004A1 (de) * | 2003-06-27 | 2005-01-13 | Kaanya Cosmetics Gmbh | Kosmetisches Verfahren zur Verminderung sichtbarer Alterungszeichen der Haut |
| US7233210B2 (en) * | 2003-08-26 | 2007-06-19 | Toshiba America Electric Components, Inc. | Spread spectrum clock generator |
| DE60333873D1 (de) * | 2003-10-03 | 2010-09-30 | Green Meadows Res Llc | Zubereitungen die Lotusextrakte und Methyldonatoren enthalten |
| US20050090518A1 (en) * | 2003-10-24 | 2005-04-28 | Nastech Pharmaceutical Company Inc. | Method for treating parkinson's disease using apomorphine and apomorphine prodrugs |
| US7473435B2 (en) * | 2004-01-12 | 2009-01-06 | Integrated Botanical Technologies, Llc | Bioactive compositions form Theacea plants and processes for their production and use |
| DE102005030864A1 (de) * | 2005-07-01 | 2007-01-25 | Beiersdorf Ag | Kosmetische Zubereitung zur Verbesserung der Hautfeuchtigkeit |
| AU2007217003B2 (en) * | 2006-02-21 | 2013-04-04 | Isp Investments Inc. | Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production |
| KR100828193B1 (ko) * | 2006-11-06 | 2008-05-08 | 박영준 | 연 추출물을 함유하는 미백, 노화방지 및 주름개선용조성물 |
| JP5212969B2 (ja) * | 2007-09-25 | 2013-06-19 | ゲオール化学株式会社 | クロマン化合物およびその製造方法 |
| KR101483440B1 (ko) * | 2008-05-02 | 2015-01-19 | (주)아모레퍼시픽 | 포제를 활용한 약용식물 추출물 및 이를 함유하는 피부외용제 조성물 |
| KR101121980B1 (ko) * | 2009-03-03 | 2012-03-09 | 김포시(농업기술센터) | 연잎 추출물 제조방법 및 이에 따른 연잎 추출물 및 이를 함유하는 화장료 조성물 |
| JP2011020965A (ja) * | 2009-07-17 | 2011-02-03 | Maruzen Pharmaceut Co Ltd | 化粧料キット及び化粧方法 |
| CN101658470B (zh) * | 2009-09-18 | 2012-02-22 | 北京欧凯纳斯科技有限公司 | 一种保湿霜及其制备方法 |
-
2011
- 2011-02-22 US US13/032,187 patent/US8277852B2/en not_active Expired - Fee Related
-
2012
- 2012-02-21 KR KR1020137024041A patent/KR20140019346A/ko not_active Abandoned
- 2012-02-21 CA CA2827773A patent/CA2827773A1/en not_active Abandoned
- 2012-02-21 CN CN201280019509.XA patent/CN103547253A/zh active Pending
- 2012-02-21 AU AU2012249188A patent/AU2012249188A1/en not_active Abandoned
- 2012-02-21 WO PCT/US2012/025899 patent/WO2012148527A2/en not_active Ceased
- 2012-02-21 CN CN201710573392.4A patent/CN107320375A/zh active Pending
- 2012-02-21 BR BR112013021274-8A patent/BR112013021274A2/pt not_active Application Discontinuation
- 2012-02-21 EP EP12718432.3A patent/EP2677999B1/en active Active
- 2012-02-21 MY MYPI2013701472A patent/MY172073A/en unknown
- 2012-02-21 JP JP2013555483A patent/JP6246593B2/ja active Active
- 2012-10-01 US US13/632,497 patent/US8668939B2/en not_active Expired - Lifetime
-
2017
- 2017-02-01 JP JP2017016696A patent/JP2017125018A/ja active Pending
- 2017-04-21 AU AU2017202660A patent/AU2017202660A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017125018A (ja) | 2017-07-20 |
| WO2012148527A2 (en) | 2012-11-01 |
| AU2012249188A1 (en) | 2013-09-05 |
| NZ614287A (en) | 2015-05-29 |
| US8277852B2 (en) | 2012-10-02 |
| CN107320375A (zh) | 2017-11-07 |
| US20110212190A1 (en) | 2011-09-01 |
| EP2677999B1 (en) | 2018-12-26 |
| MY172073A (en) | 2019-11-13 |
| CN103547253A (zh) | 2014-01-29 |
| WO2012148527A3 (en) | 2013-09-26 |
| BR112013021274A2 (pt) | 2018-07-03 |
| US8668939B2 (en) | 2014-03-11 |
| AU2017202660A1 (en) | 2017-05-11 |
| EP2677999A2 (en) | 2014-01-01 |
| CA2827773A1 (en) | 2012-11-01 |
| JP2014506594A (ja) | 2014-03-17 |
| JP6246593B2 (ja) | 2017-12-13 |
| US20130028996A1 (en) | 2013-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6246593B2 (ja) | 生物活性植物性化粧用組成物およびそれらの製造方法 | |
| US8663712B2 (en) | Bioactive botanical cosmetic compositions and processes for their production | |
| JP5875896B2 (ja) | ツバキ科植物に由来する生理活性組成物ならびにそれらを生成および使用するための工程 | |
| KR20160117769A (ko) | 베리과 열매를 섭취한 달팽이 점액을 함유하는 화장료 조성물 및 그의 제조방법 | |
| CN107106626A (zh) | 来自茶科植物的生物活性组合物及其在饮料、功能性食品、营养品、补充物等中的用途 | |
| KR101110301B1 (ko) | 쉬땅나무 추출물을 포함하는 피부미백용 화장료 조성물 | |
| KR101954275B1 (ko) | 골드키위 껍질 및 용과 껍질의 복합 추출물을 유효 성분으로 함유하는 화장료 조성물 및 이의 제조 방법 | |
| KR100604244B1 (ko) | 토마토추출물을 함유하는 화장료 조성물 | |
| WO2003063803A1 (en) | Bioactive botanical cosmetic ingredients and processes for their production | |
| Dueva-Koganov | Bioactive botanical cosmetic compositions and processes for their production | |
| NZ614287B2 (en) | Bioactive botanical cosmetic compositions and processes for their production | |
| KR20210133385A (ko) | 식물성 추출물 기반 바이오 활성화 화장품 조성물 및 이의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20130911 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20170215 Comment text: Request for Examination of Application |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 20170320 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20180619 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20181227 |
|
| PC1904 | Unpaid initial registration fee |